Daniel, Russell & Charles Co., LLC EquityNet Sponsorships
"Crossings TV is excited by this new distribution and its enhanced relationship with Comcast," said Frank Washington, CEO, Crossings TV. "We are confident that our locally focused, Asian-community-friendly approach in these key markets will enhance viewer choices and advertiser efficiency."
"Crossings TV provides one-of-a-kind programming directly tailored to a multicultural audience in the communities they serve," said David Jensen, Vice President of International Content Acquisition, Comcast Cable. "We're very pleased to expand our carriage of Crossings TV in these three markets, connecting our customers to content pertaining to their home countries and cultures."
Allete Therapeutic Solutions’ focus is metabolic disease -- in particular diabetes, heart
disease and cognitive disease. Diabetes is a medical problem of epidemic proportions.
Allete Therapeutic Solutions hallmark product is the ‘Artificial Pancreas System’ (‘APS’), licensed on an exclusive basis from Trina Health (Sacramento, CA) for management of metabolic disease, especially diabetes. APS is protected by seven (7) issued international patents.
APS is the only insulin infusion device to provide an average of 7X the background level of insulin to a patient’s portal vein (intravenously), at precise doses delivered in surges every 6 minutes. This mimicking of the normal, healthy pancreas in insulin delivery is more than 3X the amount of insulin provided by alternate insulin infusion devices, and serves as the essence of device patents and intellectual property (‘IP’).
APS is US FDA cleared and safe to use. It has garnered Medicare reimbursement and private insurer reimbursement approvals in the US for treatment of diabetes and metabolic syndrome, together with all their co-morbidities.
El Paseo Hotel, LLC is seeking an investor to invest $1.8 million for 5% ownership and a 6% preferred return. The investor’s return of principal will be secured by the City of Palm Desert (TOT Agreement). The completion of construction will be guaranteed.
The El Paseo Hotel is designed as a 154-room luxury hotel which is fully entitled and the only hotel site in the prestigious El Paseo Shopping District adjacent to the Taubman Mall “The Gardens on El Paseo”. The one mile luxury district is known as the “Rodeo Drive of the Desert”. The City of Palm Desert purchased the site for $5.5 million and is contributing the land to the project for $2.2 million dollars.
The hotel will be flagged as a Marriott Autograph Collection Hotel. Richfield Hospitality Inc. a Marriott approved full-service management firm will manage the hotel. The hotel will be constructed, by Davis Reed
construction with a bonding capacity of $500 million. Davis Reed Construction will provide a Fixed Price, Guaranteed Maximum Priced contract.
The content of this website is provided for information purposes only and nothing contained in this website should be construed as (i) a solicitation, offer or recommendation to acquire, dispose of or otherwise deal in any investment; (ii) an invitation or inducement to engage in investment activity or a financial promotion of any kind; or (iii) investment, legal, tax or other advice. You should obtain professional advice before making any investment decision. Whilst we have taken reasonable care to ensure that the information on this website is accurate at the time of last revision of the website, we accept no liability for the accuracy or completeness of, nor any responsibility or duty to update, the information contained on this website. This website may contain links to other websites and news articles that are not controlled by us. We do not endorse, nor are we to be held responsible or liable for the contents of those websites and the views and opinions expressed in the news articles are not own Daniel, Russell & Charles Co., LLC,. By view this website (PPM) and acknowledge that you have read, understood and agree to the terms of this notice.
Get Social with Us!
Daniel, Russell & Charles Co.,LLC
500 Capitol Mall, Suite 2350
Sacramento, CA. 95814
(800) 842-3511 Office
(916) 444-0823 Direct Line